| OR | 95% CI | p |
---|---|---|---|
Age ≥ 58 years | 1.12 | 0.49 to 2.55 | 0.79 |
Male gender | 1.04 | 0.44 to 2.46 | 0.93 |
Smoking | 1.36 | 0.45 to 4.12 | 0.59 |
BMI | |||
 Underweight | Reference |  |  |
 Normal weight | 0.46 | 0.05 to 3.88 | 0.48 |
 Overweight | 0.46 | 0.05 to 4.18 | 0.49 |
 Obese | 0.79 | 0.08 to 7.69 | 0.84 |
 Hypertension | 2.09 | 0.87 to 5.06 | 0.10 |
 Diabetes | 1.28 | 0.29 to 5.58 | 0.74 |
 Home lockdown | 0.62 | 0.26 to 1.50 | 0.29 |
 Use of masks and gloves | 0.64 | 0.27 to 1.51 | 0.30 |
 Contact avoidance | 0.73 | 0.31 to 1.75 | 0.48 |
 Contacts with COVID-19 | 13.01 | 5.14 to 32.91 | < 0.001 |
Diagnosis | |||
 SpA | Reference |  |  |
 PsA | 0.37 | 0.07 to 2.03 | 0.25 |
 RA | 1.03 | 0.34 to 3.08 | 0.96 |
 Disease duration ≥ 120 months | 0.65 | 0.27 to 1.53 | 0.32 |
 PDN | 2.89 | 1.26 to 6.62 | 0.01 |
PDN dose | |||
 0 mg/day | Reference |  |  |
 < 2.5 mg/day | 1.41 | 0.39 to 5.15 | 0.61 |
 ≥ 2.5 mg/day | 4.22 | 1.74 to 10.23 | 0.001 |
 HCQ | 1.21 | 0.45 to 3.29 | 0.70 |
 csDMARDs | 1.80 | 0.76 to 4.27 | 0.18 |
 b/tsDMARDs | 0.46 | 0.20 to 1.06 | 0.07 |